MEDBOT-B (02252) Sets 26 Mar 2026 Board Meeting to Approve FY2025 Results and Potential Final Dividend

Bulletin Express03-16

Shanghai MicroPort MedBot (Group) Co., Ltd. (stock code: 02252) announced that its board of directors will convene on Thursday, 26 March 2026.

The meeting agenda includes: 1. Reviewing and approving the Group’s audited financial statements for the year ended 31 December 2025. 2. Considering the recommendation of a final dividend, if any. 3. Transacting other routine corporate matters.

Board leadership remains unchanged, chaired by Dr. Zhaohua Chang, with executive directors Dr. Chao He and Mr. Yu Liu, five non-executive directors, and four independent non-executive directors.

The company will release its FY2025 results and any dividend proposal following the board’s consideration.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment